| Net loss | -154.07M |
| Depreciation and amortization | 227K |
| Stock-based compensation | 6.09M |
| Change in fair value of warrants | |
| Common stock issued in exchange for in-process research and development | 0 |
| Loss on disposal of fixed assets | 0 |
| Prepaid expenses and other current assets | -9.61M |
| Other noncurrent assets | 1K |
| Deposits | |
| Accounts payable | -194K |
| Accrued expenses | -1.54M |
| Deferred revenue | -5.26M |
| Deferred rent | |
| Net cash used in operating activities | |
| Purchases of property and equipment | -469K |
| Proceeds from sale of property and equipment | |
| Net cash used in investing activities | |
| Stockholders' capital contribution | |
| Proceeds from exercise of stock options | 551K |
| Payments to employees for repurchase of common stock | -2K |
| Proceeds from exercise of warrants | |
| Proceeds from issuance of common stock and warrants, net | |
| Proceeds from issuance of preferred stock, net | |
| Net cash provided by financing activities | |
| Net increase (decrease) in cash and cash equivalents | -46.03M |
| Cash and cash equivalents, beginning of period | 140.72M |
| Cash and cash equivalents, end of period | 94.68M |
| Cash paid for interest | 0 |
| Cash paid for income taxes | 0 |
| Supplementary disclosure of noncash investing and financing activities: | |
| Warrants issued to placement agents and investors | |
| Exercise of liability-classified warrants to common shares | |
| Supplementary disclosure of noncash investing and financing activities: | |
| Preferred stock conversion/exercise of equity-classified warrants to common stock | |
| Supplementary disclosure of noncash investing and financing activities: | |
| Preferred stock conversion/exercise of equity-classified warrants to common stock | |